Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.

Coindre JM, Hostein I, Maire G, Derré J, Guillou L, Leroux A, Ghnassia JP, Collin F, Pedeutour F, Aurias A.

J Pathol. 2004 Jul;203(3):822-30.

PMID:
15221942
2.

MDM2+/CDK4+/p53+ oral liposarcoma: case report and review of the literature.

Nikitakis NG, Lopes MA, Pazoki AE, Ord RA, Sauk JJ.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):194-201. Review.

PMID:
11505267
3.

[From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].

Pedeutour F, Maire G, Sirvent N; Groupe francophone de cytogénétique oncologique.

Bull Cancer. 2004 Apr;91(4):317-23. Review. French.

PMID:
15242313
4.

Lipomatous tumors.

Weiss SW.

Monogr Pathol. 1996;38:207-39. Review.

PMID:
8744279
5.

Well-differentiated and dedifferentiated liposarcomas.

Coindre JM, Pédeutour F, Aurias A.

Virchows Arch. 2010 Feb;456(2):167-79. doi: 10.1007/s00428-009-0815-x. Epub 2009 Aug 18. Review.

PMID:
19688222
6.

A clinicopathologic comparison of malignant fibrous histiocytoma and liposarcoma.

Spanier SS, Floyd J.

Instr Course Lect. 1989;38:407-17. Review.

PMID:
2539413
7.

Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.

Crago AM, Singer S.

Curr Opin Oncol. 2011 Jul;23(4):373-8. doi: 10.1097/CCO.0b013e32834796e6. Review.

8.

[Molecular biology of soft-tissue sarcomas].

Coindre JM.

Bull Cancer. 2010 Nov;97(11):1337-45. doi: 10.1684/bdc.2010.1213. Review. French.

PMID:
21084242
9.

Dedifferentiated liposarcoma of the spermatic cord with a hemangioendothelioma-like component: a case report and review of the literature.

Okano S, Yamamoto H, Kono S, Fujii H, Shirabe K, Maehara Y, Oda Y.

Pathol Res Pract. 2013 Sep;209(9):596-604. doi: 10.1016/j.prp.2013.06.014. Epub 2013 Jul 8. Review.

PMID:
23910173
10.

Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.

Thway K, Jones RL, Noujaim J, Zaidi S, Miah AB, Fisher C.

Adv Anat Pathol. 2016 Jan;23(1):30-40. doi: 10.1097/PAP.0000000000000101. Review.

PMID:
26645460
11.

Paratesticular dedifferentiated liposarcoma with leiomyosarcomatous differentiation: a case report with a review of literature.

Hatanaka K, Yoshioka T, Tasaki T, Tanimoto A.

Diagn Pathol. 2013 Aug 23;8:142. doi: 10.1186/1746-1596-8-142. Review.

12.

Other targetable sarcomas.

Pires de Camargo V, van de Rijn M, Maestro R, de Alava E, Madoz-Gúrpide J, Pilotti S, von Mehren M, Pedeutour F, Maki RG, Rutkowski P, Thomas DM.

Semin Oncol. 2009 Aug;36(4):358-71. doi: 10.1053/j.seminoncol.2009.06.008. Review. Erratum in: Semin Oncol. 2009 Oct;36(5):489. Maestro, Roberta [added].

PMID:
19664496
13.

Application of molecular biology to individualize therapy for patients with liposarcoma.

Abbas Manji G, Singer S, Koff A, Schwartz GK.

Am Soc Clin Oncol Educ Book. 2015:213-8. doi: 10.14694/EdBook_AM.2015.35.213. Review.

14.

Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors.

Nishio J.

J Biomed Biotechnol. 2011;2011:524067. doi: 10.1155/2011/524067. Epub 2011 Jan 11. Review.

15.

[Liposarcomas].

Terrier P.

Ann Pathol. 2012 Nov;32(5 Suppl):S108-10. doi: 10.1016/j.annpat.2012.07.004. Epub 2012 Oct 12. Review. French. No abstract available.

PMID:
23127924
16.

Liposarcoma: molecular targets and therapeutic implications.

Bill KL, Casadei L, Prudner BC, Iwenofu H, Strohecker AM, Pollock RE.

Cell Mol Life Sci. 2016 Oct;73(19):3711-8. doi: 10.1007/s00018-016-2266-2. Epub 2016 May 12. Review.

PMID:
27173057
Items per page

Supplemental Content

Write to the Help Desk